MicroRNA-Attenuated virus vaccines

Elizabeth J. Fay, Ryan A. Langlois

Research output: Contribution to journalReview article

1 Scopus citations


Live-attenuated vaccines are the most effective way to establish robust, long-lasting immunity against viruses. However, the possibility of reversion to wild type replication and pathogenicity raises concerns over the safety of these vaccines. The use of host-derived microRNAs (miRNAs) to attenuate viruses has been accomplished in an array of biological contexts. The broad assortment of effective tissue- and species-specific miRNAs, and the ability to target a virus with multiple miRNAs, allow for targeting to be tailored to the virus of interest. While escape is always a concern, effective strategies have been developed to improve the safety and stability of miRNA-attenuated viruses. In this review, we discuss the various approaches that have been used to engineer miRNA-attenuated viruses, the steps that have been taken to improve their safety, and the potential use of these viruses as vaccines.

Original languageEnglish (US)
Article number25
JournalNon-coding RNA
Issue number4
StatePublished - Oct 2 2018


  • Live-attenuated vaccine
  • RNAi
  • SiRNA

Fingerprint Dive into the research topics of 'MicroRNA-Attenuated virus vaccines'. Together they form a unique fingerprint.

  • Cite this